Unmet needs in phenylketonuria: an exploratory Italian survey among patients and caregivers

References

• van Spronsen FJ, Blau N, Harding C, et al. Phenylketonuria. Nat Rev Dis Primers. 2021;7(1):36. doi: 10.1038/s41572-021-00267-0.
   PubMed Web of Science ®Google Scholar
• Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417–1427. doi: 10.1016/S0140-6736(10)60961-0.
   PubMed Web of Science ®Google Scholar
• Hillert A, Anikster Y, Belanger-Quintana A, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234–250. doi: 10.1016/j.ajhg.2020.06.006.
   PubMed Web of Science ®Google Scholar
• van Spronsen FJ, van Wegberg AM, Ahring K, et al. Key uropean guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–756. doi: 10.1016/S2213-8587(16)30320-5.
   PubMed Web of Science ®Google Scholar
• MacDonald A, van Wegberg AMJ, Ahring K, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):171. doi: 10.1186/s13023-020-01391-y.
   PubMed Web of Science ®Google Scholar
• Thomas L, Olson A, Romani C. The impact of metabolic control on cognition, neurophysiology, and well-being in PKU: a systematic review and meta-analysis of the within-participant literature. Mol Genet Metab. 2023;138(1):106969. doi: 10.1016/j.ymgme.2022.106969.
   PubMed Web of Science ®Google Scholar
• Cleary M, Trefz F, Muntau AC, et al. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes. Mol Genet Metab. 2013;110(4):418–423. doi: 10.1016/j.ymgme.2013.09.001.
   PubMed Web of Science ®Google Scholar
• Manti F, Nardecchia F, Paci S, et al. Predictability and inconsistencies in the cognitive outcome of early treated PKU patients. J Inherit Metab Dis. 2017;40(6):793–799. doi: 10.1007/s10545-017-0082-y.
   PubMed Web of Science ®Google Scholar
• Ievers-Landis CE, Hoff AL, Brez C, et al. Situational analysis of dietary challenges of the treatment regimen for children and adolescents with phenylketonuria and their primary caregivers. J Dev Behav Pediatr. 2005;26(3):186–193. doi: 10.1097/00004703-200506000-00004.
   PubMed Web of Science ®Google Scholar
• MacDonald A, Gokmen-Ozel H, van Rijn M, et al. The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis. 2010;33(6):665–670. doi: 10.1007/s10545-010-9073-y.
   PubMed Web of Science ®Google Scholar
• Sharman R, Mulgrew K, Katsikitis M. Qualitative analysis of factors affecting adherence to the phenylketonuria diet in adolescents. Clin Nurse Spec. 2013;27(4):205–210. doi: 10.1097/NUR.0b013e31829555d5.
   PubMed Web of Science ®Google Scholar
• Witalis E, Mikoluc B, Motkowski R, et al. Phenylketonuria patients’ and their parents’ knowledge and attitudes to the daily diet – multi-centre study. Nutr Metab. 2017;14(1):57. doi: 10.1186/s12986-017-0207-1.
   Google Scholar
• Walter JH, White FJ, Hall SK, et al. How practical are recommendations for dietary control in phenylketonuria? Lancet. 2002;360(9326):55–57. doi: 10.1016/s0140-6736(02)09334-0.
   PubMed Web of Science ®Google Scholar
• Dubois EA, Cohen AF. Sapropterin. Br J Clin Pharmacol. 2010;69(6):576–577. doi: 10.1111/j.1365-2125.2010.03643.x.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Sapropterin dipharma: summary of product characteristics. 2022 [cited 2023 Aug 28]. Available from: https://www.ema.europa.eu/en/documents/product-information/sapropterin-dipharma-epar-product-information_en.pdf
   Google Scholar
• European Medicines Agency. Palynziq (pegvaliase): summary of product characteristics. 2019 [cited 2023 Aug 28]. Available from: https://www.ema.europa.eu/en/documents/product-information/palynziq-epar-product-information_en.pdf
   Google Scholar
• Thomas J, Levy H, Amato S, et al. Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM). Mol Genet Metab. 2018;124(1):27–38. doi: 10.1016/j.ymgme.2018.03.006.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Palynziq (pegvaliase-pqpz) injection for subcutaneous use: prescribing information. 2020 [cited 2023 Aug 28]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761079s010lbl.pdf
   Google Scholar
• Bratkovic D, Margvelashvili L, Tchan MC, et al. PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study. Metabolism. 2022;128:155116. doi: 10.1016/j.metabol.2021.155116.
   PubMed Web of Science ®Google Scholar
• Manti F, Caviglia S, Cazzorla C, et al. Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria. Orphanet J Rare Dis. 2022;17(1):443. doi: 10.1186/s13023-022-02488-2.
   PubMed Web of Science ®Google Scholar
• Ashe K, Kelso W, Farrand S, et al. Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments. Front Psychiatry. 2019;10:561. doi: 10.3389/fpsyt.2019.00561.
   PubMed Web of Science ®Google Scholar
• Bosch AM, Burlina A, Cunningham A, et al. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries. Orphanet J Rare Dis. 2015;10(1):80. doi: 10.1186/s13023-015-0294-x.
   PubMedGoogle Scholar
• Cazzorla C, Cegolon L, Burlina AP, et al. Quality of life (QoL) assessment in a cohort of patients with phenylketonuria. BMC Public Health. 2014;14(1):1243. doi: 10.1186/1471-2458-14-1243.
   PubMedGoogle Scholar
• Huijbregts SCJ, Bosch AM, Simons QA, et al. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: a PKU-COBESO study. Mol Genet Metab. 2018;125(1-2):96–103. doi: 10.1016/j.ymgme.2018.07.002.
   PubMed Web of Science ®Google Scholar
• Thimm E, Schmidt LE, Heldt K, et al. Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents. J Inherit Metab Dis. 2013;36(5):767–772. doi: 10.1007/s10545-012-9566-y.
   PubMed Web of Science ®Google Scholar
• Cazzorla C, Bensi G, Biasucci G, et al. Living with phenylketonuria in adulthood: the PKU ATTITUDE study. Mol Genet Metab Rep. 2018;16:39–45. doi: 10.1016/j.ymgmr.2018.06.007.
   PubMed Web of Science ®Google Scholar
• Trefz FK, van Spronsen FJ, MacDonald A, et al. Management of adult patients with phenylketonuria: survey results from 24 countries. Eur J Pediatr. 2015;174(1):119–127. doi: 10.1007/s00431-014-2458-4.
   PubMed Web of Science ®Google Scholar
• Firman SJ, Ramachandran R, Whelan K. Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria. J Hum Nutr Diet. 2022;35(6):1016–1029. doi: 10.1111/jhn.13015.
   PubMed Web of Science ®Google Scholar
• Green B, Browne R, Firman S, et al. Nutritional and metabolic characteristics of UK adult phenylketonuria patients with varying dietary adherence. Nutrients. 2019;11(10):2459. doi: 10.3390/nu11102459.
   PubMed Web of Science ®Google Scholar
• Haitjema S, Lubout CMA, Abeln D, et al. Dietary treatment in Dutch children with phenylketonuria: an inventory of associated social restrictions and eating problems. Nutrition. 2022;97:111576. doi: 10.1016/j.nut.2021.111576.
   PubMed Web of Science ®Google Scholar
• Martins AM, Pessoa ALS, Quesada AA, et al. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: results from a survey with 228 patients and their caregivers. Mol Genet Metab Rep. 2020;24:100624. doi: 10.1016/j.ymgmr.2020.100624.
   PubMed Web of Science ®Google Scholar
• Cotugno G, Nicolò R, Cappelletti S, et al. Adherence to diet and quality of life in patients with phenylketonuria. Acta Paediatr. 2011;100(8):1144–1149. doi: 10.1111/j.1651-2227.2011.02227.x.
   PubMed Web of Science ®Google Scholar
• MacDonald A, Smith TA, de Silva S, et al. The personal burden for caregivers of children with phenylketonuria: a cross-sectional study investigating time burden and costs in the UK. Mol Genet Metab Rep. 2016;9:1–5. doi: 10.1016/j.ymgmr.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Luu S, Breunig T, Drilias N, et al. A survey of eating attitudes and behaviors in adolescents and adults with phenylalanine hydroxylase deficiency. WMJ. 2020;119(1):37–43.
   PubMedGoogle Scholar
• Biasucci G, Brodosi L, Bettocchi I, et al. The management of transitional care of patients affected by phenylketonuria in Italy: review and expert opinion. Mol Genet Metab. 2022;136(2):94–100. doi: 10.1016/j.ymgme.2022.04.004.
   PubMed Web of Science ®Google Scholar
• Burlina A, Biasucci G, Carbone MT, et al. Italian national consensus statement on management and pharmacological treatment of phenylketonuria. Orphanet J Rare Dis. 2021;16(1):476. doi: 10.1186/s13023-021-02086-8.
   PubMed Web of Science ®Google Scholar
• Burlina A, Blau N. Effect of BH4 supplementation on phenylalanine tolerance. J Inherit Metab Dis. 2009;32(1):40–45. doi: 10.1007/s10545-008-0947-1.
   PubMed Web of Science ®Google Scholar
• Longo N, Siriwardena K, Feigenbaum A, et al. Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy. Genet Med. 2015;17(5):365–373. doi: 10.1038/gim.2014.109.
   PubMed Web of Science ®Google Scholar
• Levy HL, Milanowski A, Chakrapani A, et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet. 2007;370(9586):504–510. doi: 10.1016/S0140-6736(07)61234-3.
   PubMed Web of Science ®Google Scholar
• SriBhashyam S, Marsh K, Quartel A, et al. A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: a study of patients’ preferences. Mol Genet Metab Rep. 2019;21:100507.
   PubMed Web of Science ®Google Scholar